Korean Govt Rejects Industry Call For Price Cut Delay
This article was originally published in PharmAsia News
Executive Summary
The South Korean government has decided to push ahead with a drug price cut slated for early 2016 after reviewing the pharma industry's call to postpone the cut by one year. Based on an expert analysis it has conducted, the government concluded that the outbreak of Middle East Respiratory Syndrome (MERS) in the country earlier this year did not have a large impact on pharma firms' revenues.